Myriad Genetics (MYGN)
(Real Time Quote from BATS)
$26.60 USD
+0.05 (0.19%)
Updated Sep 25, 2024 10:26 AM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
MYGN 26.60 +0.05(0.19%)
Will MYGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MYGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MYGN
Here's Why Myriad Genetics (MYGN) is a Strong Momentum Stock
Here's Why Myriad Genetics (MYGN) is a Strong Momentum Stock
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Continue to Retain MYGN Stock in Your Portfolio?
Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?
New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues
Other News for MYGN
Myriad Genetics Inc (MYGN) Shares Gap Down to $27.16 on Sep 20
Myriad Genetics a new equal-weight at Morgan Stanley: sustained growth eyed
Myriad Genetics initiated with neutral view at Morgan Stanley, here's why
Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference
Myriad Genetics to share new data on genetic testing advancements